Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innate and adaptive immunity in inflammatory bowel disease.
Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Geremia A, et al. Among authors: biancheri p. Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15. Autoimmun Rev. 2014. PMID: 23774107 Review.
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
Di Sabatino A, Rovedatti L, Kaur R, Spencer JP, Brown JT, Morisset VD, Biancheri P, Leakey NA, Wilde JI, Scott L, Corazza GR, Lee K, Sengupta N, Knowles CH, Gunthorpe MJ, McLean PG, MacDonald TT, Kruidenier L. Di Sabatino A, et al. Among authors: biancheri p. J Immunol. 2009 Sep 1;183(5):3454-62. doi: 10.4049/jimmunol.0802887. Epub 2009 Jul 31. J Immunol. 2009. PMID: 19648266
New pathogenic paradigms in inflammatory bowel disease.
Di Sabatino A, Biancheri P, Rovedatti L, MacDonald TT, Corazza GR. Di Sabatino A, et al. Among authors: biancheri p. Inflamm Bowel Dis. 2012 Feb;18(2):368-71. doi: 10.1002/ibd.21735. Epub 2011 Apr 27. Inflamm Bowel Dis. 2012. PMID: 21538717 Review.
Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT. Biancheri P, et al. Eur J Immunol. 2014 Feb;44(2):370-85. doi: 10.1002/eji.201343524. Eur J Immunol. 2014. PMID: 24338958 Free article.
Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P, Brezski RJ, Di Sabatino A, Greenplate AR, Soring KL, Corazza GR, Kok KB, Rovedatti L, Vossenkämper A, Ahmad N, Snoek SA, Vermeire S, Rutgeerts P, Jordan RE, MacDonald TT. Biancheri P, et al. Gastroenterology. 2015 Nov;149(6):1564-1574.e3. doi: 10.1053/j.gastro.2015.07.002. Epub 2015 Jul 11. Gastroenterology. 2015. PMID: 26170138 Free article.
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
Di Sabatino A, Battista N, Biancheri P, Rapino C, Rovedatti L, Astarita G, Vanoli A, Dainese E, Guerci M, Piomelli D, Pender SL, MacDonald TT, Maccarrone M, Corazza GR. Di Sabatino A, et al. Among authors: biancheri p. Mucosal Immunol. 2011 Sep;4(5):574-83. doi: 10.1038/mi.2011.18. Epub 2011 Apr 6. Mucosal Immunol. 2011. PMID: 21471961 Free article.
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.
Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, Cassinotti A, Cazzola P, Markopoulos K, Massari A, Rosti V, Porro GB, Corazza GR. Bergamaschi G, et al. Among authors: biancheri p. Haematologica. 2010 Feb;95(2):199-205. doi: 10.3324/haematol.2009.009985. Epub 2009 Oct 8. Haematologica. 2010. PMID: 19815838 Free PMC article.
61 results